Free Trial

Spectaire (SPEC) Competitors

Spectaire logo
$0.0010 0.00 (0.00%)
As of 04/8/2025 12:00 PM Eastern

SPEC vs. THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, KEYS, FTV, and VLTO

Should you be buying Spectaire stock or one of its competitors? The main competitors of Spectaire include ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), Fortive (FTV), and Veralto (VLTO). These companies are all part of the "measuring and control equipment" industry.

Spectaire vs.

Spectaire (NASDAQ:SPEC) and ThermoGenesis (NASDAQ:THMO) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, community ranking, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership.

Spectaire has higher earnings, but lower revenue than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SpectaireN/AN/A$8.95MN/AN/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

ThermoGenesis received 26 more outperform votes than Spectaire when rated by MarketBeat users. Likewise, 60.47% of users gave ThermoGenesis an outperform vote while only 0.00% of users gave Spectaire an outperform vote.

CompanyUnderperformOutperform
SpectaireOutperform Votes
No Votes
Underperform Votes
1
100.00%
ThermoGenesisOutperform Votes
26
60.47%
Underperform Votes
17
39.53%

26.5% of Spectaire shares are owned by institutional investors. Comparatively, 5.8% of ThermoGenesis shares are owned by institutional investors. 25.4% of Spectaire shares are owned by insiders. Comparatively, 78.0% of ThermoGenesis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

ThermoGenesis' return on equity of 0.00% beat Spectaire's return on equity.

Company Net Margins Return on Equity Return on Assets
SpectaireN/A -81.22% 304.57%
ThermoGenesis N/A N/A N/A

In the previous week, Spectaire's average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company Overall Sentiment
Spectaire Neutral
ThermoGenesis Neutral

Spectaire has a beta of -6.54, suggesting that its share price is 754% less volatile than the S&P 500. Comparatively, ThermoGenesis has a beta of 2.47, suggesting that its share price is 147% more volatile than the S&P 500.

Summary

ThermoGenesis beats Spectaire on 6 of the 9 factors compared between the two stocks.

Remove Ads
Get Spectaire News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPEC vs. The Competition

MetricSpectaireMeasuring & controlling devices IndustryComputer SectorNASDAQ Exchange
Market Cap$18,000.00$14.72B$20.09B$6.91B
Dividend YieldN/A3.37%2.90%4.23%
P/E RatioN/A13.7636.5917.05
Price / SalesN/A8.242,241.2785.96
Price / CashN/A17.3834.5934.64
Price / Book0.002.255.303.66
Net Income$8.95M$538.63M$736.66M$247.27M
7 Day PerformanceN/A-12.83%-8.96%-9.80%
1 Month PerformanceN/A-12.32%50,332.47%-12.84%
1 Year PerformanceN/A-20.95%52,810.75%-10.68%

Spectaire Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPEC
Spectaire
N/A$0.00
flat
N/A-99.9%$18,000.00N/A0.008
THMO
ThermoGenesis
N/AN/AN/AN/A$2,000.00$9.61M0.0040
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37M0.0090
OLITW
OmniLit Acquisition
N/A$0.05
-2.5%
N/A-43.5%$0.00N/A0.003
PRENW
Prenetics Global
N/A$0.01
flat
N/A+76.7%$0.00$25.56M0.001Positive News
QSIAW
Quantum-Si
N/A$0.39
-3.8%
N/A+39.0%$0.00$3.06M0.00150Positive News
Gap Down
SMAPW
SportsMap Tech Acquisition
N/A$0.06
-18.9%
N/A+223.2%$0.00N/A0.00N/AGap Down
TT
Trane Technologies
4.6556 of 5 stars
$341.89
+1.5%
$413.69
+21.0%
+3.6%$76.68B$19.84B30.3939,000Dividend Announcement
Analyst Forecast
Positive News
Gap Up
KEYS
Keysight Technologies
4.6513 of 5 stars
$149.93
+0.1%
$184.44
+23.0%
-19.7%$25.91B$5.02B42.8415,000Positive News
Gap Up
FTV
Fortive
4.7229 of 5 stars
$73.50
+0.4%
$87.18
+18.6%
-25.6%$25.01B$6.23B31.1518,000Dividend Announcement
Analyst Forecast
VLTO
Veralto
4.0089 of 5 stars
$97.61
+0.2%
$113.50
+16.3%
-2.6%$24.16B$5.19B29.2316,000Positive News
Gap Up
Remove Ads

Related Companies and Tools


This page (NASDAQ:SPEC) was last updated on 4/9/2025 by MarketBeat.com Staff
From Our Partners